JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...

This breakthrough, which is a first in the Triad, offers a new option for patients with severe tricuspid regurgitation, a ...

Even women who felt well before pregnancy may begin to notice symptoms around 28 to 30 weeks, when the cardiovascular system reaches its peak workload.

A new minimally invasive procedure replaces a damaged heart valve through a small neck incision, potentially allowing patients to recover faster than with traditional open-heart surgery.

No one was more surprised than Dr. Rick Dearman when he was diagnosed with severe symptomatic aortic stenosis, also known as heart valve failure. As a heart surgeon, he’d treated hundreds of people ...

Valvular heart disease, also called heart valve disease, occurs when you have a diseased or damaged heart valve. When your heart pumps blood, your valves open and close to keep blood flowing in the ...

Vitamin K2 activates proteins that help drive calcium into the bones, away from blood vessels and heart valves. So, the theory that vitamin K2 would be helpful to treat or prevent osteoporosis -- or ...